Inbiogen Invests 10.2 Billion KRW in Gene Analysis Company Xenoplan
[Asia Economy Reporter Park Jun-yi] Inbiogen announced on the 28th that it has decided to acquire 233,454 shares of the genetic analysis company Genoplan for approximately 10.17539 billion KRW. As a result, Inbiogen will own 8.85% of Genoplan's shares.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Taking Vitamins for Health? The Hidden Dangers: Increased Risk of Stroke and Cancer
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Inbiogen explained, "The investment was made to expand capabilities in the new bioindustry business, enter related new industries, and enhance synergy with new businesses."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
